Company Description
ALX Oncology Holdings, Inc. operates as a clinical stage company, which engages in the research and development of therapies for cancer patients. Its objective is to provide clinical therapies for the treatment of myelodysplastic syndromes, acute myeloid leukemia, and a range of solid tumor indicati...
ALX Oncology Holdings, Inc. operates as a clinical stage company, which engages in the research and development of therapies for cancer patients. Its objective is to provide clinical therapies for the treatment of myelodysplastic syndromes, acute myeloid leukemia, and a range of solid tumor indications. The company was founded by Corey Goodman, Jaume Pons, and K. Christopher Garcia in March 2015 and is headquartered in South San Francisco, CA.
Valuation
Price to Book Ratio
1.75
Enterprise Value to EBITDA
0.41
Total Debt to Enterprise Value
0.08
Efficiency
Income Per Employee
-2,129,000.00
Liquidity
Current Ratio
9.57
Quick Ratio
9.57
Cash Ratio
9.40
Profitability
Return on Assets
-35.97
Return on Equity
-39.42
Return on Total Capital
-39.53
Return on Invested Capital
-38.41
Capital Structure
Total Debt to Total Equity
5.95
Total Debt to Total Capital
5.62
Total Debt to Total Assets
5.12
Long-Term Debt to Equity
5.56
Long-Term Debt to Total Capital
5.25
Officers and Executives
Name | Age | Officer Since | Title |
---|---|---|---|
Dr. Jaume Pons | 54 | 2015 | President, Chief Executive Officer & Director |
Dr. Michael Chang | - | 2015 | Vice President-Operations |
Mr. Peter S. García | 58 | 2020 | Chief Financial Officer |
Dr. Sophia Randolph | 52 | 2016 | Chief Medical Officer |
Insider Actions
12/29/2022 |
Jaume Pons President & CEO; Director |
3,232 | Disposition at $11.07 per share. | 35,778 |
12/29/2022 |
Sophia Randolph Chief Medical Officer; Director |
1,617 | Disposition at $11.07 per share. | 17,900 |
12/29/2022 |
Shelly Pinto VP, Finance and CAO |
482 | Disposition at $11.07 per share. | 5,335 |
12/29/2022 |
Peter S. García Chief Financial Officer |
893 | Disposition at $11.07 per share. | 9,885 |
12/16/2022 |
Sophia Randolph Chief Medical Officer; Director |
25,339 | Derivative/Non-derivative trans. at $4.81 per share. | 121,880 |
12/16/2022 |
Sophia Randolph Chief Medical Officer; Director |
12,731 | Derivative/Non-derivative trans. at $4.08 per share. | 51,942 |
12/16/2022 |
Sophia Randolph Chief Medical Officer; Director |
8,404 | Derivative/Non-derivative trans. at $1.91 per share. | 16,051 |
08/05/2022 |
Jaume Pons President & CEO; Director |
74,000 | Award at $0 per share. | 0 |
08/05/2022 |
Sophia Randolph Chief Medical Officer; Director |
37,000 | Award at $0 per share. | 0 |
08/05/2022 |
Shelly Pinto VP, Finance and CAO |
11,000 | Award at $0 per share. | 0 |
08/05/2022 |
Peter S. García Chief Financial Officer |
29,000 | Award at $0 per share. | 0 |
02/07/2022 |
Peter S. García Chief Financial Officer |
8,363 | Derivative/Non-derivative trans. at $4.81 per share. | 40,226 |
02/07/2022 |
Peter S. García Chief Financial Officer |
6,637 | Derivative/Non-derivative trans. at $4.08 per share. | 27,078 |
02/03/2022 |
Jaume Pons President & CEO; Director |
12,254 | Derivative/Non-derivative trans. at $1.91 per share. | 23,405 |
02/03/2022 |
Jaume Pons President & CEO; Director |
11,900 | Derivative/Non-derivative trans. at $0.99 per share. | 11,781 |
01/28/2022 |
Shelly Pinto VP, Finance and CAO |
50,000 | Award at $0 per share. | 0 |
12/15/2021 |
Sophia Randolph Chief Medical Officer; Director |
11,059 | Derivative/Non-derivative trans. at $1.91 per share. | 21,122 |
12/15/2021 |
Sophia Randolph Chief Medical Officer; Director |
12,793 | Derivative/Non-derivative trans. at $0.99 per share. | 12,665 |
12/13/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
60 | Disposition at $30.23 per share. | 1,813 |
12/13/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
440 | Disposition at $30.23 per share. | 13,301 |
12/13/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
181 | Disposition at $29.6 per share. | 5,357 |
12/13/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
1,329 | Disposition at $29.6 per share. | 39,338 |
12/13/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
299 | Disposition at $28.37 per share. | 8,482 |
12/13/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
2,196 | Disposition at $28.37 per share. | 62,300 |
12/13/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
1,296 | Disposition at $27.49 per share. | 35,627 |
12/13/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
9,509 | Disposition at $27.49 per share. | 261,402 |
12/13/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
2,339 | Disposition at $26.48 per share. | 61,936 |
12/13/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
17,169 | Disposition at $26.48 per share. | 454,635 |
12/13/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
1,627 | Disposition at $25.29 per share. | 41,146 |
12/13/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
11,945 | Disposition at $25.29 per share. | 302,089 |
12/13/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
60 | Disposition at $30.23 per share. | 1,813 |
12/13/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
440 | Disposition at $30.23 per share. | 13,301 |
12/13/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
181 | Disposition at $29.6 per share. | 5,357 |
12/13/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
1,329 | Disposition at $29.6 per share. | 39,338 |
12/13/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
299 | Disposition at $28.37 per share. | 8,482 |
12/13/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
2,196 | Disposition at $28.37 per share. | 62,300 |
12/13/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
1,296 | Disposition at $27.49 per share. | 35,627 |
12/13/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
286,496 | Disposition at $27.49 per share. | 7,875,775 |
12/13/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
2,339 | Disposition at $26.48 per share. | 61,936 |
12/13/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
17,169 | Disposition at $26.48 per share. | 454,635 |
12/13/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
1,627 | Disposition at $25.29 per share. | 41,146 |
12/13/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
11,945 | Disposition at $25.29 per share. | 302,089 |
12/10/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
12 | Disposition at $32.16 per share. | 385 |
12/10/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
88 | Disposition at $32.16 per share. | 2,830 |
12/10/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
2,172 | Disposition at $31.55 per share. | 68,526 |
12/10/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
15,942 | Disposition at $31.55 per share. | 502,970 |
12/10/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
967 | Disposition at $30.77 per share. | 29,754 |
12/10/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
7,093 | Disposition at $30.77 per share. | 218,251 |
12/10/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
12 | Disposition at $32.16 per share. | 385 |
12/10/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
88 | Disposition at $32.16 per share. | 2,830 |
12/10/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
2,172 | Disposition at $31.55 per share. | 68,526 |
12/10/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
15,942 | Disposition at $31.55 per share. | 502,970 |
12/10/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
967 | Disposition at $30.77 per share. | 29,754 |
12/10/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
7,093 | Disposition at $30.77 per share. | 218,251 |
12/09/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
1,911 | Disposition at $32.73 per share. | 62,547 |
12/09/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
14,028 | Disposition at $32.73 per share. | 459,136 |
12/09/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
5,751 | Disposition at $32.06 per share. | 184,377 |
12/09/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
42,203 | Disposition at $32.06 per share. | 1,353,028 |
12/09/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
1,560 | Disposition at $31.08 per share. | 48,484 |
12/09/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
11,452 | Disposition at $31.08 per share. | 355,928 |
12/09/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
1,911 | Disposition at $32.73 per share. | 62,547 |
12/09/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
14,028 | Disposition at $32.73 per share. | 459,136 |
12/09/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
5,751 | Disposition at $32.06 per share. | 184,377 |
12/09/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
42,203 | Disposition at $32.06 per share. | 1,353,028 |
12/09/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
1,560 | Disposition at $31.08 per share. | 48,484 |
12/09/2021 |
LSV CAPITAL MANAGEMENT LLC Director |
11,452 | Disposition at $31.08 per share. | 355,928 |
MarketWatch News on ALXO
-
ALX Oncology stock price target cut to $16 from $35 at Stifel Nicolaus
- Tomi Kilgore
-
ALX Oncology stock price target cut to $36 from $60 at Stifel Nicolaus
- Tomi Kilgore
-
ALX Oncology initiated at buy with $106 target price at Stifel
- Tonya Garcia
-
ALX Oncology started at buy with $96 stock price target at UBS
- Tomi Kilgore
-
Biotech stocks are a buy — especially these 18 picks
- Michael Brush
-
ALX Oncology sets IPO terms, to raise up to $136 million
- Tomi Kilgore
Other News on ALXO
-
These Biotechs Were Told Their SVB Funds Were Available. It Wasn’t That Simple.
- The Wall Street Journal Interactive Edition
-
10-Q: ALX ONCOLOGY HOLDINGS INC
- Edgar Online - (EDG = 10Q, 10K)
-
ALX Oncology (ALXO) Investor Presentation - Slideshow
- Seeking Alpha
-
Monster Moves Among Russell 3,000 Stocks
- Seeking Alpha
-
10-Q: ALX ONCOLOGY HOLDINGS INC
- Edgar Online - (EDG = 10Q, 10K)
-
ALX Oncology files for $450 mixed shelf offering
- Seeking Alpha
-
ALX Oncology Is Turning Into An Also-Ran In Anti-CD47
- Seeking Alpha
-
New Strong Sell Stocks for January 19th
- Zacks.com
-
ALX Oncology plunges as director sells shares worth $75M
- Seeking Alpha
- Loading more headlines...